5.4med

CVE-2023-2139

Reflected Cross-site Scripting vulnerability affecting DELMIA Apriso Release 2017 through Release 2022

Published 3 y ago · modified 4 mo ago · JSON

CVSS
5.4
v3.1 · CNA
CISA KEV
No
not known exploited
EPSS
0.4%
percentile 29%
Public exploits
0
none known

Summary

A reflected Cross-site Scripting (XSS) Vulnerability in DELMIA Apriso Release 2017 through Release 2022 allows an attacker to execute arbitrary script code.

CISA SSVC assessment

Exploitation
none
Automatable
no
Technical impact
partial
Assessed
21 mo ago

Exploit prediction (EPSS)

0.35% probability of exploitation in the next 30 days, higher than 29% of all scored CVEs.

CVSS scores

Assigned byVersionScoreVector
CNA3.15.4CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
CNA3.15.4CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
NVD3.16.1CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Affected products

  • Dassault Systèmes DELMIA Apriso

Classification

Weakness
  • CWE-79 Improper Neutralization of Input During Web Page Generation

References

  • 3ds.com /vulnerability/advisories · x_transferred

Sources

vulnwire keeps one entry per vulnerability: the CVE id wins, then GHSA; records that alias each other are merged. Machine-readable: JSON.